Vanzacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, specifically classified as a potentiator designed to improve chloride transport in epithelial cells for the treatment… Read more
Vanzacaftor is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator, specifically classified as a potentiator designed to improve chloride transport in epithelial cells for the treatment of cystic fibrosis. This category offers high-quality reference standards essential for pharmaceutical analysis, including the parent drug, its stable isotope labelled compound, and specific degradation products. Laboratories utilize Vanzacaftor-d4 as an internal standard in mass spectrometry for accurate metabolic tracing and quantification, while N-Nitroso Vanzacaftor is critical for impurity profiling and rigorous stability testing. By providing these well-characterized materials, this collection supports precise analytical validation, method development, and quality control workflows. These reference standards ensure that analytical procedures remain robust and compliant, facilitating the accurate identification and quantification of impurities and metabolites throughout the drug development and manufacturing lifecycle.